- The Easynose, the new nebulization system for nasal delivery has been selected for a phase III clinical study in patients with chronic rhinosinusitis (CRS patients). The trial is currently in recruitment.
Aerodrug, Faculté de Médecine, Bâtiment M, 10 ter boulevard Tonnellé, 37032 TOURS France.